Literature DB >> 28669356

Prevalence and Predictors of Postdischarge Antibiotic Use Following Mastectomy.

Margaret A Olsen1, Katelin B Nickel1, Victoria J Fraser1, Anna E Wallace2, David K Warren1.   

Abstract

OBJECTIVE Survey results suggest that prolonged administration of prophylactic antibiotics is common after mastectomy with reconstruction. We determined utilization, predictors, and outcomes of postdischarge prophylactic antibiotics after mastectomy with or without immediate breast reconstruction. DESIGN Retrospective cohort. PATIENTS Commercially insured women aged 18-64 years coded for mastectomy from January 2004 to December 2011 were included in the study. Women with a preexisting wound complication or septicemia were excluded. METHODS Predictors of prophylactic antibiotics within 5 days after discharge were identified in women with 1 year of prior insurance enrollment; relative risks (RR) were calculated using generalized estimating equations. RESULTS Overall, 12,501 mastectomy procedures were identified; immediate reconstruction was performed in 7,912 of these procedures (63.3%). Postdischarge prophylactic antibiotics were used in 4,439 procedures (56.1%) with immediate reconstruction and 1,053 procedures (22.9%) without immediate reconstruction (P.05). CONCLUSIONS Prophylactic postdischarge antibiotics are commonly prescribed after mastectomy; immediate reconstruction is the strongest predictor. Stewardship efforts in this population to limit continuation of prophylactic antibiotics after discharge are needed to limit antimicrobial resistance. Infect Control Hosp Epidemiol 2017;38:1048-1054.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28669356      PMCID: PMC5645083          DOI: 10.1017/ice.2017.128

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  39 in total

Review 1.  Antibiotic use in aesthetic surgery: a national survey and literature review.

Authors:  John A Perrotti; Stanley A Castor; Phillip C Perez; James E Zins
Journal:  Plast Reconstr Surg       Date:  2002-04-15       Impact factor: 4.730

2.  Duration of antibiotics after microsurgical breast reconstruction does not change surgical infection rate.

Authors:  Daniel Z Liu; Janelle A Dubbins; Otway Louie; Hakim K Said; Peter C Neligan; David W Mathes
Journal:  Plast Reconstr Surg       Date:  2012-02       Impact factor: 4.730

3.  Impact of Postoperative Antibiotic Prophylaxis Duration on Surgical Site Infections in Autologous Breast Reconstruction.

Authors:  Kerry E Drury; Steven T Lanier; Nima Khavanin; Keith M Hume; Karol A Gutowski; Brian P Thornton; Nora M Hansen; Robert X Murphy; Neil A Fine; John Y S Kim
Journal:  Ann Plast Surg       Date:  2016-02       Impact factor: 1.539

Review 4.  Antimicrobial Stewardship: A Call to Action for Surgeons.

Authors:  Massimo Sartelli; Therese M Duane; Fausto Catena; Jeffrey M Tessier; Federico Coccolini; Lillian S Kao; Belinda De Simone; Francesco M Labricciosa; Addison K May; Luca Ansaloni; John E Mazuski
Journal:  Surg Infect (Larchmt)       Date:  2016-11-09       Impact factor: 2.150

5.  Antimicrobial Prophylaxis Practice Patterns in Breast Augmentation: A National Survey of Current Practice.

Authors:  Karan Chopra; Arvind U Gowda; Colton H L McNichols; Emile N Brown; Sheri Slezak; Yvonne Rasko
Journal:  Ann Plast Surg       Date:  2017-06       Impact factor: 1.539

6.  Use of prophylactic postoperative antibiotics during surgical drain presence following mastectomy.

Authors:  Brandy L Edwards; George J Stukenborg; David R Brenin; Anneke T Schroen
Journal:  Ann Surg Oncol       Date:  2014-08-20       Impact factor: 5.344

7.  Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States.

Authors:  Reshma Jagsi; Jing Jiang; Adeyiza O Momoh; Amy Alderman; Sharon H Giordano; Thomas A Buchholz; Steven J Kronowitz; Benjamin D Smith
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

8.  Postoperative antibiotic prophylaxis for implant-based breast reconstruction with acellular dermal matrix.

Authors:  Yash J Avashia; Raja Mohan; ChiChi Berhane; John C Oeltjen
Journal:  Plast Reconstr Surg       Date:  2013-03       Impact factor: 4.730

9.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

10.  Development of a Risk Prediction Model to Individualize Risk Factors for Surgical Site Infection After Mastectomy.

Authors:  Margaret A Olsen; Katelin B Nickel; Julie A Margenthaler; Ida K Fox; Kelly E Ball; Daniel Mines; Anna E Wallace; Graham A Colditz; Victoria J Fraser
Journal:  Ann Surg Oncol       Date:  2016-01-28       Impact factor: 5.344

View more
  3 in total

1.  Effectiveness of Single vs Multiple Doses of Prophylactic Intravenous Antibiotics in Implant-Based Breast Reconstruction: A Randomized Clinical Trial.

Authors:  Jessica Gahm; Anna Ljung Konstantinidou; Jakob Lagergren; Kerstin Sandelin; Martin Glimåker; Hemming Johansson; Marie Wickman; Jana de Boniface; Jan Frisell
Journal:  JAMA Netw Open       Date:  2022-09-01

2.  Extended Prophylactic Antibiotics for Mastectomy with Immediate Breast Reconstruction: A Meta-analysis.

Authors:  Yang Hai; Weelic Chong; Melissa A Lazar
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-01-27

3.  Feasibility and safety of discontinuation of isolation precaution policy for coronavirus disease 2019 (COVID-19) patients from COVID-19 units to general medical units in Thailand.

Authors:  Anucha Apisarnthanarak; David K Warren; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2021-07-21       Impact factor: 6.520

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.